SORRENTO THERAPEUTICS, INC.: cash_and_equivalents

Value{"amount": 5277578, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2010-12-31)
Statuscurrent
EntitySORRENTO THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-11-221290 · Open the official SEC filing →
Retrieved: 2026-08-19T08:26:02.612026+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000850261/cash-and-equivalents/2010-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d435eb51-2e8e-49cc-ad05-cfd3cf7086b9

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies